Canada Markets open in 6 hrs 2 mins
  • S&P/TSX

    -142.37 (-0.69%)
  • S&P 500

    -52.79 (-1.30%)
  • DOW

    -260.99 (-0.77%)

    -0.0026 (-0.3536%)

    -0.63 (-0.81%)

    -1,081.66 (-3.39%)
  • CMC Crypto 200

    -17.00 (-3.16%)

    -14.50 (-0.75%)
  • RUSSELL 2000

    -25.74 (-1.35%)
  • 10-Yr Bond

    0.0000 (0.00%)
  • NASDAQ futures

    +4.25 (+0.04%)

    +1.43 (+7.73%)
  • FTSE

    -13.26 (-0.17%)
  • NIKKEI 225

    -106.29 (-0.39%)

    -0.0007 (-0.10%)

Fairfax India Holdings Corporation: Third Quarter Financial Results

Fairfax India Holdings Corporation
Fairfax India Holdings Corporation


(Note: All dollar amounts in this press release are expressed in U.S. dollars except as otherwise noted. The financial results are derived from financial statements prepared using the recognition and measurement requirements of International Financial Reporting Standards as issued by the International Accounting Standards Board ("IFRS"), except as otherwise noted, and are unaudited. This press release contains certain non-GAAP and other financial measures, including book value per share and cash and marketable securities, that do not have a prescribed meaning under IFRS and may not be comparable to similar financial measures presented by other issuers. See "Glossary of non-GAAP and other financial measures" in the company's Interim Report for the three and nine months ended September 30, 2022 for further details.)

TORONTO, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Fairfax India Holdings Corporation (TSX: FIH.U) announces net earnings of $112.6 million in the third quarter of 2022 ($0.79 net earnings per diluted share), compared to net earnings of $131.9 million in the third quarter of 2021 ($0.85 net earnings per diluted share).

Highlights for the third quarter of 2022 include the following:

  • Net change in unrealized gains on investments of $153.7 million, principally from an increase in the fair value of the company's investments in NSE ($56.4 million), Fairchem Organics ($39.4 million), CSB Bank ($33.5 million), IIFL Finance ($31.0 million), IIFL Wealth ($13.8 million) (net of unrealized losses of $43.1 million related to a forward sale derivative), 5paisa ($4.7 million) and Saurashtra ($4.3 million), partially offset by a decrease in the fair value of Sanmar ($24.7 million) and NCML common shares ($5.9 million).

  • On September 5, 2022 the company completed the second closing of its investment in Maxop and invested $21.9 million (approximately 1.8 billion Indian rupees) for an incremental 16.0% equity interest in Maxop.

  • The company continued to buy back shares under its normal course issuer bid and in the first nine months of 2022 purchased for cancellation 2,552,225 subordinate voting shares at a net cost of $31.2 million ($12.21 per subordinate voting share).

  • In accordance with the Investment Advisory Agreement, which provides for the payment of a performance fee of 20% of the increase in book value per share in excess of a hurdle rate of 5% per annum, the company recorded a performance fee of $4.8 million for third quarter of 2022 and at September 30, 2022 had accrued $34.3 million to the benefit of Fairfax Financial Holdings. The performance fee, if any, will only be finally determined on December 31, 2023 at the end of the three year measurement period.

  • At September 30, 2022 common shareholders' equity was $2,600.6 million, or book value per share of $18.75, compared to $2,774.8 million, or book value per share of $19.65, at December 31, 2021, a decrease of 4.6%, primarily related to unrealized foreign currency translation losses as a result of the weakening of the Indian rupee relative to the U.S. dollar, partially offset by net earnings and the impact of share purchases for cancellation during the first nine months of 2022.

Fairfax India is in strong financial health, with cash and marketable securities of approximately $167 million.

There were 138.8 million and 145.5 million weighted average common shares outstanding during the third quarters of 2022 and 2021 respectively. At September 30, 2022 there were 108,683,127 subordinate voting shares and 30,000,000 multiple voting shares outstanding.

Fairfax India's detailed third quarter report can be accessed at its website

Fairfax India Holdings Corporation is an investment holding company whose objective is to achieve long term capital appreciation, while preserving capital, by investing in public and private equity securities and debt instruments in India and Indian businesses or other businesses with customers, suppliers or business primarily conducted in, or dependent on, India.

For further information, contact:

John Varnell, Vice President, Corporate Affairs


(416) 367-4755

This press release may contain forward-looking statements within the meaning of applicable securities legislation. Forward-looking statements may relate to the company's or an Indian Investment's future outlook and anticipated events or results and may include statements regarding the financial position, business strategy, growth strategy, budgets, operations, financial results, taxes, dividends, plans and objectives of the company. Particularly, statements regarding future results, performance, achievements, prospects or opportunities of the company, an Indian Investment, or the Indian market are forward-looking statements. In some cases, forward-looking statements can be identified by the use of forward-looking terminology such as “plans”, “expects” or “does not expect”, “is expected”, “budget”, “scheduled”, “estimates”, “forecasts”, “intends”, “anticipates” or “does not anticipate” or “believes”, or variations of such words and phrases or state that certain actions, events or results “may”, “could”, “would”, “might”, “will” or “will be taken”, “occur” or “be achieved”. 

Forward-looking statements are based on our opinions and estimates as of the date of this press release, and they are subject to known and unknown risks, uncertainties, assumptions and other factors that may cause the actual results, level of activity, performance or achievements to be materially different from those expressed or implied by such forward-looking statements, including but not limited to the following factors: the COVID-19 pandemic; oil price risk; geographic concentration of investments; foreign currency fluctuation; volatility of the Indian securities markets; investments may be made in foreign private businesses where information is unreliable or unavailable; valuation methodologies involve subjective judgments; financial market fluctuations; pace of completing investments; minority investments; reliance on key personnel and risks associated with the Investment Advisory Agreement; lawsuits; use of leverage; significant ownership by Fairfax may adversely affect the market price of the subordinate voting shares; weather risk; taxation risks; emerging markets; MLI; economic risk; and trading price of subordinate voting shares relative to book value per share risk. Additional risks and uncertainties are described in the company's annual information form dated March 4, 2022 which is available on SEDAR at and on the company's website at These factors and assumptions are not intended to represent a complete list of the factors and assumptions that could affect the company. These factors and assumptions, however, should be considered carefully.

Although the company has attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements. The company does not undertake to update any forward-looking statements contained herein, except as required by applicable securities laws.